Shukra Pharma Secures Rs.11.59 Cr RMSCL Supply Order

Shukra Pharmaceuticals Limited

Shukra Pharmaceuticals has received a Letter of Acceptance from Rajasthan Medical Services Corporation Limited (RMSCL) on June 24, 2025. The company has been awarded a Rate Contract cum Supply Agreement for providing essential pharmaceutical formulations to government-run healthcare institutions across Rajasthan. The contract is valued at Rs. 11.59 crore, with the supply period extending through December 2026.

Location:  Rajasthan

Estimated Value (Rs. Cr): 11.59

Sector: Drugs/Pharma

Project Stage: Contract Award

Contact Details: You need to be a paid subscriber to get these details. Contacts are available in the ProjectX India 1st July 2025 PDF Edition.

. Do you want to buy this issue or our latest issue? If yes! click here

*Image used in this post if any, is for illustration only

India Projects News | Drugs/Pharma sector Project News

ProjectX India fortnightly PDF edition empowers you with new projects in India, accelerating your business with timely information on upcoming and ongoing projects, contract awards, and tenders. Discover actionable new project opportunities and access related contacts with ease. Delivered straight to your inbox every fortnight, ProjectX India keeps you ahead with the latest project insights.

Do subscribe and get 24 fortnightly issues in a year.  Click here to know more

Do you want to try out a copy of ProjectX India PDF edition?

Click here to try out an evaluation copy that covers new projects from India, ongoing projects from India, contract awards from India, and public procurement opportunities from India.


WhatsApp us at 877 927 9155 for subscriptions or advertising on this website and digital edition.